{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:03:53Z","timestamp":1777525433199,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":644,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1093\/annonc\/mdx692","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T11:08:48Z","timestamp":1508843328000},"page":"361-369","source":"Crossref","is-referenced-by-count":58,"title":["Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive\/Advanced Cancer of the Urothelium (RISC)"],"prefix":"10.1016","volume":"29","author":[{"given":"A.","family":"Bamias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tzannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.C.","family":"Harshman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Crabb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-N.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kumar Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ladoire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.Y.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Niegisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.N.","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Vaishampayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cerbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Liontos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Powles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bellmunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Galsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1093\/annonc\/mdx692_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clgc.2011.11.005","article-title":"Administration of cisplatin-based chemotherapy for advanced urothelial carcinoma in the community","volume":"10","author":"Sonpavde","year":"2012","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1093\/annonc\/mdx692_bb0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/cncr.22031","article-title":"Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder","volume":"107","author":"Dash","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1093\/annonc\/mdx692_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.urology.2004.04.024","article-title":"Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: phase II study of the Hellenic Co-operative Oncology Group","volume":"64","author":"Linardou","year":"2004","journal-title":"Urology"},{"issue":"5\u20136","key":"10.1093\/annonc\/mdx692_bb0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000132394","article-title":"Biweekly carboplatin\/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment","volume":"73","author":"Bamias","year":"2007","journal-title":"Oncology"},{"issue":"17","key":"10.1093\/annonc\/mdx692_bb0030","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0959-8049(01)00295-7","article-title":"A feasibility study of carboplatin with fixed dose of gemcitabine in \u201cunfit\u201d patients with advanced bladder cancer","volume":"37","author":"Bellmunt","year":"2001","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1093\/annonc\/mdx692_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000012132","article-title":"Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function","volume":"59","author":"Carles","year":"2000","journal-title":"Oncology"},{"issue":"33","key":"10.1093\/annonc\/mdx692_bb0040","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1200\/JCO.2008.21.4924","article-title":"Randomized phase II\/III trial assessing gemcitabine\/carboplatin and methotrexate\/carboplatin\/vinblastine in patients with advanced urothelial cancer \u201cunfit\u201d for cisplatin-based chemotherapy: phase II\u2013results of EORTC study 30986","volume":"27","author":"De Santis","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1093\/annonc\/mdx692_bb0045","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1200\/JCO.1999.17.10.3173","article-title":"Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy","volume":"17","author":"Bajorin","year":"1999","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1093\/annonc\/mdx692_bb0050","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1200\/JCO.2011.34.8433","article-title":"Treatment of patients with metastatic urothelial cancer \u201cunfit\u201d for Cisplatin-based chemotherapy","volume":"29","author":"Galsky","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdx692_bb0055","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.clgc.2015.09.009","article-title":"Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: a Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)","volume":"14","author":"Bamias","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1093\/annonc\/mdx692_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.eururo.2016.09.042","article-title":"Nomogram-based prediction of overall survival in patients with metastatic urothelial carcinoma receiving first-line platinum-based chemotherapy: Retrospective International Study of Invasive\/Advanced Cancer of the Urothelium (RISC)","volume":"71","author":"Necchi","year":"2017","journal-title":"Eur Urol"},{"issue":"7","key":"10.1093\/annonc\/mdx692_bb0065","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1076029616668405","article-title":"Retrospective International Study of Cancers of the Urothelium (RISC) Investigators. The Khorana Score in predicting venous thromboembolism for patients with metastatic urothelial carcinoma and variant histology treated with chemotherapy","volume":"23","author":"Ramos","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10.1093\/annonc\/mdx692_bb0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cam4.986","article-title":"RISC Investigators. Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival","volume":"6","author":"Ramos","year":"2017","journal-title":"Cancer Med"},{"key":"10.1093\/annonc\/mdx692_bb0075","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1200\/JCO.2001.19.10.2638","volume":"19","author":"Sternberg","year":"2001","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1093\/annonc\/mdx692_bb0080","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"von der Maase","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx692_bb0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.2004.02.152","article-title":"Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group","volume":"22","author":"Bamias","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdx692_bb0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/annonc\/mds583","article-title":"Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine\/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16\/03)","volume":"24","author":"Bamias","year":"2013","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1093\/annonc\/mdx692_bb0095","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/JCO.2011.38.6979","article-title":"Randomized phase III study comparing paclitaxel\/cisplatin\/gemcitabine and gemcitabine\/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987","volume":"30","author":"Bellmunt","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10064","key":"10.1093\/annonc\/mdx692_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1093\/annonc\/mdx692_bb0105","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1093\/annonc\/mdu223","article-title":"Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Bellmunt","year":"2014","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419350392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419350392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/29\/2\/361\/23980112\/mdx692.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:44:02Z","timestamp":1624697042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419350392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0923753419350392"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdx692","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}